Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy
Santarsieri, Anna, Mitchell, Emily, Sturgess, Katherine, Brice, Pauline, Menne, Tobias F., Osborne, Wendy, Creasey, Thomas, Ardeshna, Kirit M., Behan, Sarah, Bhuller, Kaljit, Booth, Stephen, Chavda, Nikesh D., Collins, Graham P., Culligan, Dominic J., Cwynarski, Kate, Davies, Andrew, Downing, Abigail, Dutton, David, Furtado, Michelle, Gallop-Evans, Eve, Hodson, Andrew, Hopkins, David, Hsu, Hannah, Iyengar, Sunil, Jones, Stephen G., Linton, Kim M., Lomas, Oliver C., Martinez-Calle, Nicolas, Mathur, Abhinav, McKay, Pamela, Nagumantry, Sateesh K., O'Mahony, Deirdre, Phillips, Elizabeth H., Phillips, Neil, Rudge, John F., Shah, Nimish K., Stafford, Gwyneth, Sternberg, Alex, Trickey, Rachel, Uttenthal, Benjamin J., Wetherall, Natasha, McMillan, Andrew K., Stratton, Michael, Laurenti, Elisa, Campbell, Peter J., Follows, George A.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article